Andrew P. Blackaby
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Synthesis and biological activity, Cytokine Signaling Pathways and Interactions, Pharmacogenetics and Drug Metabolism, Microfluidic and Capillary Electrophoresis Applications
Most-Cited Works
- → Engineering a polyketide with a longer chain by insertion of an extra module into the erythromycin-producing polyketide synthase(2001)82 cited
- → Novel octaketide macrolides related to 6-deoxyerythronolide B provide evidence for iterative operation of the erythromycin polyketide synthase(2000)80 cited
- → Identification and cloning of a type III polyketide synthase required for diffusible pigment biosynthesis in Saccharopolyspora erythraea‡(2002)67 cited
- → Discovery of Novel Ansamycins Possessing Potent Inhibitory Activity in a Cell-based Oncostatin M Signalling Assay.(2000)40 cited
- → Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach(2009)21 cited
- → Magnetic resonance imaging of the HPLC processElectronic supplementary information (ESI) available: Colour movie clips of three-dimensional peak profile data. See http://www.rsc.org/suppdata/an/b3/b312244a/(2004)2 cited
- → Production of novel derivatives of a gastrin antagonist (GW1) using biotransformation(1998)
- → ChemInform Abstract: Discovery of Novel Ansamycins Possessing Potent Inhibitory Activity in a Cell‐Based Oncostatin M Signaling Assay(2000)